이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Icade 미래 성장

Future 기준 확인 3/6

Icade (는) 각각 연간 125.3% 및 4.3% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 120% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 5.9% 로 예상됩니다.

주요 정보

122.3%

수익 성장률

112.4%

EPS 성장률

REITs 수익 성장	61.5%
매출 성장률	4.3%
향후 자기자본 수익률	5.9%
애널리스트 커버리지	Good
마지막 업데이트	02 Jul 2024

최근 미래 성장 업데이트

Recent updates

수익 및 매출 성장 예측

ENXTPA:ICAD - 애널리스트의 미래 추정치 및 과거 재무 데이터 (EUR Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	1,595	247	N/A	282	4
12/31/2025	1,531	133	N/A	254	4
12/31/2024	1,465	-1	N/A	229	3
12/31/2023	1,525	-1,289	238	238	N/A
9/30/2023	1,494	-1,116	317	317	N/A
6/30/2023	1,825	-519	468	468	N/A
3/31/2023	1,827	-232	390	390	N/A
12/31/2022	1,469	-370	242	242	N/A
9/30/2022	1,496	-61	N/A	N/A	N/A
6/30/2022	1,524	249	547	224	N/A
3/31/2022	1,586	324	538	377	N/A
12/31/2021	1,648	399	529	529	N/A
6/30/2021	1,640	280	-51	600	N/A
3/31/2021	1,534	178	34	625	N/A
12/31/2020	1,429	76	120	650	N/A
6/30/2020	1,458	259	-233	453	N/A
3/31/2020	1,485	278	-325	411	N/A
12/31/2019	1,512	298	-417	369	N/A
9/30/2019	1,587	235	-317	358	N/A
6/30/2019	1,662	173	-218	346	N/A
3/31/2019	1,717	165	-193	351	N/A
12/31/2018	1,773	156	-169	356	N/A
9/30/2018	1,714	137	-258	372	N/A
6/30/2018	1,655	118	-348	387	N/A
3/31/2018	1,642	142	-344	362	N/A
12/31/2017	1,629	165	-340	337	N/A
6/30/2017	1,596	106	N/A	255	N/A
3/31/2017	1,542	75	N/A	235	N/A
12/31/2016	1,487	45	N/A	215	N/A
6/30/2016	1,391	-101	N/A	309	N/A
3/31/2016	1,411	-144	N/A	307	N/A
12/31/2015	1,431	-187	N/A	305	N/A
6/30/2015	1,649	82	N/A	526	N/A
3/31/2015	1,687	116	N/A	506	N/A
12/31/2014	1,725	151	N/A	486	N/A
9/30/2014	1,683	111	N/A	342	N/A
6/30/2014	1,602	79	N/A	199	N/A
3/31/2014	1,540	103	N/A	184	N/A
12/31/2013	1,479	127	N/A	170	N/A
9/30/2013	1,467	71	N/A	128	N/A

애널리스트 미래 성장 예측

수입 대 저축률: ICAD 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률( 1.1% )보다 빠른 성장으로 간주됩니다.

수익 vs 시장: ICAD (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.

고성장 수익: ICAD 향후 3년 내에 수익을 낼 것으로 예상됩니다.

수익 대 시장: ICAD 의 수익(연간 4.3% ) French 시장( 5.8% 보다 느리게 성장할 것으로 예상됩니다. 5.8% 연간).

고성장 수익: ICAD 의 수익(연간 4.3% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: ICAD 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 5.9 %).

Icade 미래 성장

Future 기준 확인 3/6

주요 정보

최근 미래 성장 업데이트

Price target decreased by 7.8% to €29.59

Price target decreased by 8.3% to €32.09

Price target decreased by 7.9% to €32.82

Consensus EPS estimates upgraded to €6.67 loss, revenue downgraded

Consensus EPS estimates fall by 69%

Consensus EPS estimates fall by 63%

Recent updates

Now 23% undervalued after recent price drop

Now 25% undervalued after recent price drop

Now 25% undervalued after recent price drop

Now 31% undervalued after recent price drop

Now 23% undervalued after recent price drop

Now 21% undervalued

Now 20% undervalued

Price target decreased by 7.8% to €29.59

Price target decreased by 8.3% to €32.09

Price target decreased by 7.9% to €32.82

Dividend of €2.42 announced

Now 21% undervalued after recent price drop

Upcoming dividend of €2.42 per share

Icade, Annual General Meeting, Apr 19, 2024

Consensus EPS estimates upgraded to €6.67 loss, revenue downgraded

Consensus EPS estimates fall by 69%

Consensus EPS estimates fall by 63%

Icade to Report Q1, 2024 Results on Apr 22, 2024

Icade to Report First Half, 2024 Results on Jul 22, 2024

Icade to Report Fiscal Year 2023 Results on Feb 19, 2024

Icade(ENXTPA:ICAD) dropped from FTSE All-World Index (USD)

Price target decreased by 7.3% to €41.55

Consensus EPS estimates fall by 160%

Now 20% undervalued after recent price drop

Primonial REIM and Société Générale Assurances completed the acquisition of 63% stake in Icade Santé SAS from Icade (ENXTPA:ICAD) and its Minority Shareholders.

Upcoming dividend of €2.17 per share at 12% yield

Consensus estimates of losses per share improve by 75%

Vauban Infrastructure Partners and Icade (ENXTPA:ICAD) agreed to acquire A2A Coriance SAS.

Consensus EPS estimates fall by 17%, revenue upgraded

Oteis France Sas agreed to acquire AMO and EXPERTISE SANTE activity from Icade (ENXTPA:ICAD).

Consensus EPS estimates fall by 17%

Consensus estimates of losses per share improve by 16%

Consensus EPS estimates fall by 15%

An undisclosed buyer acquired Michigan Garden Project from Icade SA (ENXTPA:ICAD) for €108 million.

Icade SA (ENXTPA:ICAD) acquired Défense Parc complex in Nanterre Préfecture for €63 million.

Icade SA to Report Q1, 2023 Results on Apr 24, 2023

Icade SA to Report Fiscal Year 2022 Results on Feb 20, 2023

Consensus forecasts updated

Consensus forecasts updated

Elysées Pierre signed a bilateral preliminary agreement to acquire 16,000-Sq.m AXE 13 Office Building in Nanterre from Icade (ENXTPA:ICAD).

Investor sentiment deteriorated over the past week

Upcoming dividend of €2.10 per share

Funds managed by Primonial REIM acquired Gambetta building in paris from Icade (ENXTPA:ICAD) for approximately €220 million.

Funds managed by Primonial REIM acquired Gambetta building in paris from Icade (ENXTPA:ICAD) for approximately €220 million.

Residences Le Logement Des Fonctionnaires SA signed a bilateral preliminary agreement to acquire Residual Residential Portfolio from Icade (ENXTPA:ICAD) for €49.9 million.

Icade (ENXTPA:ICAD) acquired 50.1% interest in M&A Group.

Consensus forecasts updated

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Consensus forecasts updated

An unknown buyer completed the acquisition of Office building in Boulogne-Billancourt from Icade SA (ENXTPA:ICAD).

Consensus EPS estimates increase to €1.91

Consensus EPS estimates increase to €1.10

First half 2021 earnings released: EPS €2.52 (vs €0.07 in 1H 2020)

Consensus forecasts updated

Revenue beats expectations, earnings disappoint

A Look At Icade's (EPA:ICAD) Share Price Returns

New 90-day low: €55.50

Analysts update estimates

How Did Icade SA's (EPA:ICAD) 8.0% ROE Fare Against The Industry?

A pan-European fund dedicated to a German institutional investor managed by Aberdeen Standard Investments Limited acquired Two residential buildings in Rueil-Malmaison from Icade SA (ENXTPA:ICAD) for €14.6 million.

Icade SA (ENXTPA:ICAD) acquired Ad Vitam

Icade SA to Report Q1, 2021 Results on Apr 23, 2021

Icade SA (ENXTPA:ICAD) agreed to acquire Four Nursing Homes in France from Korian (ENXTPA:KORI) for €33.5 million.

What Type Of Shareholders Make Up Icade SA's (EPA:ICAD) Share Registry?

New 90-day high: €68.20

Market bids up stock over the past week

New 90-day low: €42.96

New 90-day low: €48.00